Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,885 | 51,049 | 89,397 | 112,879 | -88,981 |
| Depreciation Amortization | 637 | 783 | 956 | -17 | 535 |
| Accounts receivable | -4,268 | -7,580 | N/A | N/A | -50 |
| Other Working Capital | 16,346 | -629 | 490 | 11,613 | -28,140 |
| Other Operating Activity | 39,755 | 32,416 | 15,562 | 7,352 | 29,785 |
| Operating Cash Flow | $45,585 | $76,039 | $106,405 | $131,827 | $-86,851 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -670 | -438 | -306 | -152 | -203 |
| Purchase Of Investment | -322,722 | -224,494 | -200,569 | -19,016 | -167,272 |
| Sale Of Investment | 136,580 | 99,181 | 66,030 | 32,800 | 60,000 |
| Investing Cash Flow | $-186,812 | $-125,751 | $-134,845 | $13,632 | $-107,475 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 96,387 | 4,046 | 1,558 | 1,004 | 10,678 |
| Other Financing Activity | 1,002 | 1,002 | 370 | 370 | 120,416 |
| Financing Cash Flow | $97,389 | $5,048 | $1,928 | $1,374 | $131,094 |
| Beginning Cash Position | 128,779 | 128,779 | 128,780 | 128,780 | 192,011 |
| End Cash Position | 84,941 | 84,115 | 102,268 | 275,613 | 128,779 |
| Net Cash Flow | $-43,838 | $-44,664 | $-26,512 | $146,833 | $-63,232 |
| Free Cash Flow | |||||
| Operating Cash Flow | 45,585 | 76,039 | 106,405 | 131,827 | -86,851 |
| Capital Expenditure | -670 | -438 | -306 | -152 | -203 |
| Free Cash Flow | 44,915 | 75,601 | 106,099 | 131,675 | -87,054 |